NEW YORK (GenomeWeb) – Abbott reported Wednesday morning that first quarter sales in its Diagnostics business grew 4 percent year over year, driven by strong growth in core laboratory and point-of-care sales.

For the three months ended March 31, Abbott reported overall Q1 revenues of $6.34 billion, up 30 percent on a reported basis from Q1 last year, and up 3 percent on a comparable basis accounting for the acquisition of St. Jude Medical closed in January. The company beat the consensus Wall Street estimate of $6.15 billion.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.